Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

Description:
High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Module Objectives:

Review concepts of who should undergo an ASCT, eligibility and treatment decision making
Provide a brief overview of the ASCT process
Identify special nursing considerations for the community-based provider

Instructor:
Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

An exciting novel treatment for patients with myeloma

Using the patient’s own immune system to destroy myeloma cells.

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.